Home
  >  
Section 16
  >  
Chapter 15,121

Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms

Tophkhane, C.; Yang, S.; Bales, W.; Archer, L.; Osunkoya, A.; Thor, A.D.; Yang, X.

International Journal of Oncology 31(4): 867-874

2007

ISSN/ISBN: 1019-6439
PMID: 17786319
DOI: 10.3892/ijo.31.4.867
Accession: 015120696
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Genistein is a soy isoflavone with anti-tumor properties. Genistein-induced apoptosis involves Bcl-2 down-regulation. However, overexpression of Bcl-2 in breast cancer has been associated with better prognosis and response to hormonal therapy. To examine genistein's effect on breast cancer cells with different Bcl-2 levels, we established control (MCF-7/PV) and Bcl-2 overexpressing MCF-7 (MCF-7/Bcl-2) cell lines and characterized genistein regulated apoptosis and cell cycle progression in these cells. Our results demonstrate that overexpression of Bcl-2 rendered MCF-7 cells more sensitive, rather than resistant, to genistein. We found that genistein induces enhanced cytochrome c release and mitochondrial membrane depolarization in MCF-7/Bcl-2 cells, as compared to control. We also found that genistein increases Bcl-2 levels and Bcl-2/Bax ratio in the mitochondrial fractions of MCF-7/Bcl-2 cells, suggesting that disturbed Bcl-2/Bax distribution may cause cytochrome c release and apoptosis in these cells. Cell cycle analysis indicated that genistein induces G0/G1 arrest in MCF-7/PV cells but increases in G2/M arrest in MCF-7/Bcl-2 cells. This was accompanied by modified responses of several cell cycle regulators, such as p21 and cyclin B I. Taken together, our results indicate that genistein-Bcl-2 interaction switches Bcl-2 from an antiapoptotic protein into a proapoptotic protein, which involves disturbed Bcl-2/Bax distribution in mitochondria, increased cytochrome c release and modified cell cycle regulation.

PDF emailed within 0-6 h: $19.90




Related References

Borradaile, N.M.; de Dreu, L.E.; Wilcox, L.J.; Edwards, J.Y.; Huff, M.W. 2002: Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms Biochemical Journal 366(Part 2): 531-539
Salama, S.; Diaz-Arrastia, C.; Patel, D.; Botting, S.; Hatch, S. 2011: 2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms International Journal of Radiation Oncology Biology Physics 80(1): 231-239
Gill, C.; Walsh, S.E.; Morrissey, C.; Fitzpatrick, J.M.; Watson, R.W.G. 2007: Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosisthrough multiple mechanisms The Prostate 67(15): 1641-1653
Gill, C.; Walsh, S.E.; Morrissey, C.; Fitzpatrick, J.M.; Watson, R.William.G. 2007: Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms Prostate 67(15): 1641-1653
Kolev, M.V.; Ruseva, M.M.; Morgan, B.P.; Donev, R.M. 2010: Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanisms Journal of Immunology 184(11): 6035-6042
Chiawpanit, C.; Panwong, S.; Sawasdee, N.; Yenchitsomanus, P.-T.; Panya, A. 2022: Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to be Susceptible to Natural Killer Cells Biology 11(8)
Jin, C.-Y.; Park, C.; Cheong, J.; Choi, B.T.; Lee, T.H.; Lee, J.-D.; Lee, W.H.; Kim, G.-Y.; Ryu, C.H.; Choi, Y.H. 2007: Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3 Cancer Letters 257(1): 56-64
Kolev, M.V.; Morgan, B.Paul.; Ruseva, M.M.; Donev, R.M. 2011: Retraction. Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanisms Journal of Immunology 187(12): 6581
Jin, C.-Y.; Park, C.; Moon, S.-K.; Kim, G.-Y.; Kwon, T.K.; Lee, S.J.; Kim, W.-J.; Choi, Y.H. 2009: Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage Anti-Cancer Drugs 20(8): 713-722
Liu, X.X.; Sun, C.; Jin, X.D.; Li, P.; Zheng, X.G.; Zhao, T.; Li, Q. 2016: Genistein sensitizes sarcoma cells in vitro and in vivo by enhancing apoptosis and by inhibiting DSB repair pathways Journal of Radiation Research 57(3): 227-237
Huang Yanhong; Yuan Peng; Zhang Qinghong; Xin Xiaoyan 2009: Genistein sensitizes ovarian carcinoma cells to chemotherapy by switching the cell cycle progression in vitro Journal of Medical Colleges of Pla 24(3): 125-135
Beranova, L.; Pombinho, A.R.; Spegarova, J.; Koc, M.; Klanova, M.; Molinsky, J.; Klener, P.; Bartunek, P.; Andera, L. 2013: The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms Apoptosis: An International Journal on Programmed Cell Death 18(6): 739-750
Wang, Y.; Wang, H.; Zhang, W.; Shao, C.; Xu, P.; Shi, C.H.; Shi, J.G.; Li, Y.M.; Fu, Q.; Xue, W.; Lei, Y.H.; Gao, J.Y.; Wang, J.Y.; Gao, X.P.; Li, J.Q.; Yuan, J.L.; Zhang, Y.T. 2013: Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis Plos one 8(1): E50175
Kim, I.G.; Kim, J.S.; Lee, J.H.; Cho, E.W. 2014: Genistein decreases cellular redox potential, partially suppresses cell growth in HL‑60 leukemia cells and sensitizes cells to γ‑radiation‑induced cell death Molecular Medicine Reports 10(6): 2786-2792
Mai, Z.; Blackburn, G.L.; Zhou, J.-R. 2007: Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells Molecular Carcinogenesis 46(7): 534-542
Liu, X.; Li, P.; Hirayama, R.; Niu, Y.; Liu, X.; Chen, W.; Jin, X.; Zhang, P.; Ye, F.; Zhao, T.; Liu, B.; Li, Q. 2018: Genistein sensitizes glioblastoma cells to carbon ions via inhibiting DNA-PKcs phosphorylation and subsequently repressing NHEJ and delaying HR repair pathways RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 129(1): 84-94
Bannas, P.; Scheuplein, F.; Well, L.; Hermans-Borgmeyer, I.; Haag, F.; Koch-Nolte, F. 2011: Transgenic overexpression of toxin-related ecto-ADP-ribosyltransferase ART2.2 sensitizes T cells but not B cells to NAD-induced cell death Molecular Immunology 48(15-16): 1762-1770
Russo, A.J.; Magro, P.G.; Hu, Z.; Li, W.-W.; Peters, R.; Mandola, J.; Banerjee, D.; Bertino, J.R. 2006: E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents Cancer Research 66(14): 7253-7260
Sumantran, V.N.; Ealovega, M.W.; Nuñez, G.; Clarke, M.F.; Wicha, M.S. 1995: Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis Cancer Research 55(12): 2507-2510
Dong, Y.Bin.; Yang, H.Liang.; McMasters, K.M. 2003: E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin Cancer Gene Therapy 10(3): 168-178